Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 8
- 0 vs. Q4 2021
- Portfolio value
- $224.8M
- −$104.3M (−31.7%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CPNGCoupang, Inc. | CL A | 3,046,571 | $53.9M | 24.0% | −118,000−3.7% | Reduced | History |
| RCUSArcus Biosciences, Inc. | COM | 1,612,077 | $50.9M | 22.6% | 00.0% | Unchanged | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,819,690 | $40.4M | 18.0% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $32.2M | 14.3% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $29.1M | 12.9% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,000,000 | $12.8M | 5.7% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $5.38M | 2.4% | 00.0% | Unchanged | History |
| DIDIYDiDi Global Inc. | SPONSORED ADS | 91,085 | $228.0K | 0.1% | +91,085 | New | History |
Sold out since Q4 2021 (1)
Positions held at the end of Q4 2021 that are gone from this filing.